Source: DiaCarta Blog

DiaCarta Blog Detection of ROS1, RET, and ALK fusions in non-small cell lung cancer

Read full article »
DiaCarta's Competitors | DiaCarta's News | DiaCarta's Financials
Stay up-to-date with the latest news on DiaCarta
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Aiguo Zhang's photo - President & CEO of DiaCarta

President & CEO

Aiguo Zhang

CEO Approval Rating

50/100

Read more
Stay up-to-date with the latest news on DiaCarta